Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaojun Julia Liang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|May 7, 2024
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An UpdateLaura Hillebrand, Xiaojun Julia Liang, Ricardo A M Serafim, et al.
International Journal of Molecular Sciences|December 9, 2020
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTKMichael Forster, Xiaojun Julia Liang, Martin Schröder, et al.
Drug Design, Development and Therapy|April 1, 2025
Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSPLarissa N Ernst, Simon J Jaag, Valentin R Wydra, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2024
Probing the Protein Kinases' Cysteinome by Covalent FragmentsGuiqun Wang, Nico J Seidler, Sandra Röhm, et al.
Journal of Medicinal Chemistry|July 13, 2026
Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase InhibitorsXiaojun Julia Liang, Claudia Albertini, Thales Kronenberger, et al.
Nature Communications|September 2, 2025
Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1Barbara Orth, Pavel Pohl, Florian Aust, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|May 7, 2024
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An UpdateLaura Hillebrand, Xiaojun Julia Liang, Ricardo A M Serafim, et al.
International Journal of Molecular Sciences|December 9, 2020
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTKMichael Forster, Xiaojun Julia Liang, Martin Schröder, et al.
Drug Design, Development and Therapy|April 1, 2025
Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSPLarissa N Ernst, Simon J Jaag, Valentin R Wydra, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2024
Probing the Protein Kinases' Cysteinome by Covalent FragmentsGuiqun Wang, Nico J Seidler, Sandra Röhm, et al.
Journal of Medicinal Chemistry|July 13, 2026
Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase InhibitorsXiaojun Julia Liang, Claudia Albertini, Thales Kronenberger, et al.
Nature Communications|September 2, 2025
Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1Barbara Orth, Pavel Pohl, Florian Aust, et al.
Pageof 1